"The U.S. Food and Drug Administration is alerting hospitals, health care professionals, and patients of a voluntary recall of all non-expired drug products produced and distributed for sterile use by Abrams Royal Compounding Pharmacy in Dallas, T"...
HYLENEX (hyaluronidase human injection) is contraindicated in patients with known hypersensitivity to hyaluronidase or any of the excipients in HYLENEX (hyaluronidase human injection) . A preliminary skin test for hypersensitivity to HYLENEX recombinant (hyaluronidase human injection) can be performed. The skin test is made by an intradermal injection of approximately 0.02 mL (3 Units) of a 150 Unit/mL solution. A positive reaction consists of a wheal with pseudopods appearing within 5 minutes and persisting for 20 to 30 minutes and accompanied by localized itching. Transient vasodilation at the site of the test, i.e., erythema, is not a positive reaction.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 12/29/2009
Additional Hylenex Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.